| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034895164 |
| P356 | DOI | 10.1186/1757-2215-7-76 |
| P932 | PMC publication ID | 4127950 |
| P698 | PubMed publication ID | 25296567 |
| P5875 | ResearchGate publication ID | 266680756 |
| P2093 | author name string | Masahide Ohmichi | |
| Yoshito Terai | |||
| Hiroshi Sasaki | |||
| Hiroshi Kawaguchi | |||
| Akiko Tanabe | |||
| Keisuke Ashihara | |||
| Masanori Kanemura | |||
| Satoe Fujiwara | |||
| Satoshi Tsunetoh | |||
| Tomohito Tanaka | |||
| Yoshimichi Tanaka | |||
| Masaaki Takai | |||
| P2860 | cites work | The SLUG zinc-finger protein represses E-cadherin in breast cancer | Q24292674 |
| Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
| E-cadherin-catenin cell-cell adhesion complex and human cancer | Q28142886 | ||
| The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells | Q28143877 | ||
| Correlation of Snail expression with histological grade and lymph node status in breast carcinomas | Q28206944 | ||
| The snail superfamily of zinc-finger transcription factors | Q28216843 | ||
| Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis | Q28283104 | ||
| The radioresistance biological function of the SCF/kit signaling pathway is mediated by the zinc-finger transcription factor Slug | Q28513207 | ||
| Snail blocks the cell cycle and confers resistance to cell death | Q28572344 | ||
| The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression | Q28595042 | ||
| Complex networks orchestrate epithelial-mesenchymal transitions | Q29547478 | ||
| The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion | Q29616467 | ||
| Molecular requirements for epithelial-mesenchymal transition during tumor progression | Q29618960 | ||
| Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression | Q33495389 | ||
| Mutations and Chromosomal Rearrangements Affecting the Expression of Snail, a Gene Involved in Embryonic Patterning in DROSOPHILA MELANOGASTER. | Q33950513 | ||
| Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas | Q34053843 | ||
| Snail/slug family of repressors: slowly going into the fast lane of development and cancer | Q34071809 | ||
| Transitions between epithelial and mesenchymal states in development and disease | Q34761972 | ||
| Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer | Q35769582 | ||
| Expression of E-cadherin in primary and metastatic prostate cancer. | Q35773636 | ||
| Treatment goals in ovarian cancer | Q36102311 | ||
| Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer | Q36591911 | ||
| The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients | Q36614683 | ||
| Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression. | Q36902961 | ||
| Distinct mechanisms of tumor invasion and metastasis | Q36991647 | ||
| Epithelial-mesenchymal transition in cancer development and its clinical significance | Q37644546 | ||
| Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines | Q40252973 | ||
| Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level | Q40442732 | ||
| The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. | Q40590650 | ||
| Cadherins in cancer: implications for invasion and metastasis | Q40780329 | ||
| Evidence for a function of CtBP in epithelial gene regulation and anoikis | Q40860404 | ||
| Elevated expression of E-cadherin and alpha-, beta-, and gamma-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas | Q45201662 | ||
| Transcriptional repressor snail and progression of human hepatocellular carcinoma | Q47766615 | ||
| Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. | Q53376881 | ||
| High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. | Q54545606 | ||
| Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. | Q54677737 | ||
| The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes | Q59650980 | ||
| E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas | Q71804951 | ||
| Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion | Q72430757 | ||
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 76 | |
| P577 | publication date | 2014-07-27 | |
| P1433 | published in | Journal of Ovarian Research | Q27721898 |
| P1476 | title | The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer | |
| P478 | volume | 7 |
| Q27323906 | A Novel High-Throughput 3D Screening System for EMT Inhibitors: A Pilot Screening Discovered the EMT Inhibitory Activity of CDK2 Inhibitor SU9516 |
| Q49235662 | Activation of the LKB1‑SIK1 signaling pathway inhibits the TGF‑β‑mediated epithelial‑mesenchymal transition and apoptosis resistance of ovarian carcinoma cells |
| Q92167818 | Biguanides in combination with olaparib limits tumorigenesis of drug-resistant ovarian cancer cells through inhibition of Snail |
| Q52642950 | CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway. |
| Q33721133 | CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways |
| Q47095768 | Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition |
| Q37036493 | Docosahexaenoic Acid Modulates Invasion and Metastasis of Human Ovarian Cancer via Multiple Molecular Pathways |
| Q38804452 | E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer |
| Q64107373 | EMT Markers in Locally-Advanced Prostate Cancer: Predicting Recurrence? |
| Q37694339 | Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways |
| Q55237224 | Expression and clinical significance of autophagic protein LC3B and EMT markers in gastric cancer. |
| Q58710004 | Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer |
| Q41530251 | Ginsenoside Rb1 inhibits hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells by regulating microRNA-25 |
| Q40467868 | HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma. |
| Q47107385 | Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent manner |
| Q42430169 | High tumor-associated macrophages infiltration is associated with poor prognosis and may contribute to the phenomenon of epithelial-mesenchymal transition in gastric cancer |
| Q55240408 | IGHG1 promotes motility likely through epithelial-mesenchymal transition in ovarian cancer. |
| Q39476144 | Identification of a lncRNA involved functional module for esophageal cancer subtypes |
| Q35538822 | Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cells |
| Q91705744 | Knockdown of ROS proto-oncogene 1 inhibits migration and invasion in gastric cancer cells by targeting the PI3K/Akt signaling pathway |
| Q90192635 | LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway |
| Q47115139 | Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells |
| Q47137856 | Low expression of GATA3 promotes cell proliferation and metastasis in gastric cancer |
| Q91698979 | METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition |
| Q64232940 | MicroRNA-16 inhibits migration and invasion via regulation of the Wnt/β-catenin signaling pathway in ovarian cancer |
| Q48124146 | Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells |
| Q90083321 | Ovarian Primary and Metastatic Tumors Suppressed by Survivin Knockout or a Novel Survivin Inhibitor |
| Q37702541 | Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy. |
| Q90480539 | Pharmacokinetic evaluation and antitumor potency of liposomal nanoparticle encapsulated cisplatin targeted to CD24-positive cells in ovarian cancer |
| Q55404911 | Protein expression patterns in cancer-associated fibroblasts and cells undergoing the epithelial-mesenchymal transition in ovarian cancers. |
| Q38629150 | Proteomics of cell-cell interactions in health and disease. |
| Q98513630 | ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target |
| Q48199478 | Snail-mediated cancer stem cell-like phenotype in human CNE2 nasopharyngeal carcinoma cell |
| Q42317503 | Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer |
| Q57071538 | The activation of microRNA-520h-associated TGF-β1/c-Myb/Smad7 axis promotes epithelial ovarian cancer progression |
| Q51002803 | The role of metastasis-associated in colon cancer 1 (MACC1) in endometrial carcinoma tumorigenesis and progression. |
| Q58706941 | miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway |
Search more.